Video

View G. Steven Burrill's Presentation from BioConference Live
November 17, 2009.

View video 

Podcast

Jerry Flanagan, healthcare policy director for ConsumerWatchdog, discusses his group’s lawsuit against Anthem Blue Cross of California over its rate hikes, what they mean for healthcare reform, and why the proposed healthcare legislation wouldn’t have prevented Anthem from instituting the rate increases in the first place.
Hear the podcast 

G. Steven Burrill

Welcome from the CEO

Flash required to view this video. Download the latest version here

 G. Steven Burrill 
 
Sign up for a free subscription to The Burrill Weekly Brief 
Sign up to receive email notifications about our upcoming events and news.



Simon Waddington

Entrepreneur-in-Residence

Simon D. Waddington is an Entrepreneur-in-Residence at Burrill. He is involved in building startup companies across Burrill & Company’s sectors of interest and coordinates Burrill’s global team to conceptualize and build regional newcos in Asia, Latin America and the Middle East/Africa. He serves as the CEO of Abunda, a Burrill incubated startup.

Prior to Burrill, he spent more than a decade as a venture capitalist. He was a Managing Partner at PolyTechnos Venture-Partners based in Munich, Germany where he led and supported investments for numerous life science and materials-related companies across Europe, Israel, and the United States. Prior to that, he started and ran Monsanto’s European corporate venturing activities from Brussels, Belgium, covering opportunities across the medical, agricultural, nutrition, healthcare services and materials arenas. Before that he was Product Development Manager in the United Kingdom for Zeneca’s biopolymers business, which pioneered the fermentation-based production of biodegradable polymers from renewable feedstocks. Prior to that he served as a Senior Research Scientist for ICI specializing in surface and interface science: his work on the development and advancement of surface analysis methods led to a long-standing interest in nanoscience and he was a co-founder of the European NanoBusiness Association and served on its Advisory Board.

His investment activities have broadly spanned the physical, chemical, and biological sectors and as such he has developed a keen interest in business requiring an interdisciplinary context such as medical devices. His functional roles in industry have included corporate venturing, business development and strategy, product development, applied science, and basic research. He has worked in the United Kingom, United States, Belgium and Germany. He holds a Ph.D. in physics and an MBA from Harvard Business School.